title: [Continuous dopaminergic stimulation in Parkinson disease].
authors.forename: J A
authors.initials: JA
authors.lastname: Obeso
authors.forename: M R
authors.initials: MR
authors.lastname: Luquin
authors.forename: J
authors.initials: J
authors.lastname: Vaamonde
authors.forename: F
authors.initials: F
authors.lastname: Grandas
authors.forename: M A
authors.initials: MA
authors.lastname: Pastor
authors.forename: J
authors.initials: J
authors.lastname: Artieda
authors.forename: J M
authors.initials: JM
authors.lastname: Martínez-Lage
mesh_terms: D001058:Apomorphine / Q000008:administration & dosage* / Q000627:therapeutic use; D015259:Dopamine Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004873:Ergolines / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral; D007980:Levodopa / Q000008:administration & dosage* / Q000627:therapeutic use; D008090:Lisuride / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010078:Oxazines / Q000008:administration & dosage* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D010477:Perfusion / Q000379:methods
chemical_list: D015259:Dopamine Agents; D004873:Ergolines; D010078:Oxazines; C042631:naxagolide; D007980:Levodopa; D008090:Lisuride; D001058:Apomorphine
vernacular_title: Estimulación dopaminérgica continua en la enfermedad de Parkinson.